LYMPH NODE METASTASIS AS A SOLE PRESENTATION OF NASOPHARYNGEAL CARCINOMA
Main Article Content
Keywords
Nasopharyngeal carcinoma; cervical lymphadenopathy; occult primary tumor; lymph node metastasis; Epstein–Barr virus; head and neck cancer; non-keratinizing carcinoma; diagnostic delay
Abstract
Introduction: Nasopharyngeal carcinoma (NPC) is a distinct head and neck malignancy with unique epidemiological and biological characteristics. In many cases, NPC initially presents with cervical lymph node metastasis before the identification of the primary tumor. Rarely, lymph node metastasis may be the sole initial clinical manifestation, leading to diagnostic delay and clinical challenges.
Objective: To highlight the clinic pathological features of patients presenting with cervical lymph node metastasis as the only initial presentation of Nasopharyngeal carcinoma.
Materials and Methods: This observational study was conducted in the Department of ENT and Head and Neck Surgery at Ayub teaching Hospital MTI, Abbottabad., and included 30 patients presenting with isolated cervical lymphadenopathy subsequently diagnosed as nasopharyngeal carcinoma (NPC). Patients underwent detailed clinical examination, contrast-enhanced CT/MRI of the head and neck, nasopharyngoscopy, and histopathological evaluation of lymph node and nasopharyngeal biopsy specimens. Immunohistochemistry and Epstein–Barr virus (EBV)-encoded RNA testing were performed where indicated. Demographic, clinical, radiological, and pathological findings were analyzed using descriptive statistical methods.
Results: Most patients presented with painless, firm cervical lymph nodes, predominantly in the upper deep cervical chain. In several cases, the nasopharyngeal primary tumor was clinically occult and detected only on imaging or endoscopic evaluation. Histopathology confirmed non-keratinizing undifferentiated carcinoma in the majority of cases. Epstein–Barr virus (EBV)-associated markers were positive in most patients. Delayed identification of the primary site was associated with advanced nodal stage at presentation.
Conclusion: Cervical lymph node metastasis may represent the sole presenting feature of NPC. A high index of suspicion, especially in endemic regions, is essential for early diagnosis. Comprehensive evaluation of unexplained cervical lymphadenopathy should always include assessment of the nasopharynx to avoid diagnostic delay and improve outcomes.
References
2. Chang ET, Ye W, Zeng YX, Adami HO. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiology, Biomarkers & Prevention. 2021 Jun 1;30(6):1035-47.
3. Su ZY, Siak PY, Lwin YY, Cheah SC. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer and Metastasis Reviews. 2024 Sep;43(3):919-39.
4. Liu Q, Wang H, Chen Z, Xiong J, Huang Y, Zhang S, Zhang Q. Global, regional, and national epidemiology of nasopharyngeal carcinoma in middle-aged and elderly patients from 1990 to 2021. Ageing research reviews. 2025 Feb 1;104:102613.
5. Lee HM, Okuda KS, Gonzalez FE, Patel V. Current perspectives on nasopharyngeal carcinoma. Human cell transformation: advances in cell models for the study of cancer and aging. 2019 Oct 2:11-34.
6. Jiang W, Zheng B, Wei H. Recent advances in early detection of nasopharyngeal carcinoma. Discover Oncology. 2024 Aug 23;15(1):365.
7. Rjoub Y, Rahaifeh SA. Epstein-Barr Virus and Nasopharyngeal Carcinoma: A Review on Virology, Oncogenic Mechanisms, and Clinical Implications. Electronic Journal of Medical Research. 2025 Nov 18;1(2):14-22.
8. Wang X, Hu D, Li R, Liao W, Li C, Liu Q, Li J, Li Q, Guo W, Wang L, Zhang S. Epstein-Barr virus-associated tumors: commonalities in pathogenesis and the tumor immune microenvironment. Frontiers in Immunology. 2026 Apr 24;17:1791347.
9. Edition F. Husband & Reznek’s Imaging in Oncology.
10. Lakshmiah S. Investigating carbohydrate metabolism in head and neck cancer by analysing the roles of p53, TIGAR, and Hexokinase 2 (Doctoral dissertation, The University of Liverpool (United Kingdom)).
11. Adham M, Lazim NM, Carlos R. Clinical presentation of nasopharyngeal carcinoma. InAn evidence-based approach to the management of nasopharyngeal cancer 2020 Jan 1 (pp. 93-109). Academic Press.
12. Vemula A, Dhanasekaran SP, VEMULA A. Uncommon Presentations of Nasopharyngeal Carcinoma: A Report of Two Cases. Cureus. 2024 Sep 18;16(9).
13. Ling W, Nie J, Zhang D, Yang Q, Jin H, Ou X, Ma X, Luo Y. Role of contrast-enhanced ultrasound (CEUS) in the diagnosis of cervical lymph node metastasis in nasopharyngeal carcinoma (NPC) patients. Frontiers in Oncology. 2020 Jul 17;10:972.
14. Zhong Z, Wang D, Liu Y, Shao S, Chen S, He S, Yang N, Li C, Ren J, Zhao Y, Wang Q. Lymph drainage and cervical fascia anatomy-oriented differential nodal CTV delineation at the supraclavicular region for esophageal cancer and nasopharyngeal cancer. Radiotherapy and Oncology. 2022 Dec 1;177:113-20.
15. Mabaso MA. The Association Between Epstein-Barr Virus and Nasopharyngeal Carcinoma (Master's thesis, University of the Witwatersrand, Johannesburg (South Africa)).
16. Song J, Kim JY, Kim S, Park Y. Utility of Epstein-Barr viral load in blood for diagnosing and predicting prognosis of lymphoma: a comparison with Epstein-Barr virus–encoded RNA in situ hybridization. The Journal of Molecular Diagnostics. 2022 Sep 1;24(9):977-91.

